Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Neoplasms of the CNS

Free Subscription 17.11.2025 1 BMC Cancer 1 BMC Neurol 1 Br J Cancer 1 Br J Neurosurg 2 Childs Nerv Syst 1 Int J Radiat Oncol Biol Phys 1 J Neurol Neurosurg Psychiatry 8 J Neurooncol 2 J Neuropathol Exp Neurol 1 J Neurosurg 1 Nat Rev Neurol 9 Neuro Oncol 1 Neuroradiology 3 Neurosurgery 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. WANG Y, Chao Q, Lu X, Zhou Y, et al
   Clinical features and prognostic factors of ovarian cancer brain metastases from ovarian cancer: a retrospective multicenter study of 129 cases.
   BMC Cancer. 2025;25:1729.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. ADEYEMO TA, Greenley S, Ware F, Haque F, et al
   Evidence gap in predicting intracranial haemorrhage risk in people with glioma on anticoagulants: a scoping review.
   BMC Neurol. 2025;25:458.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. LIU H, Pan Z, Yang Q, Dai L, et al
   Insulin signalling-associated cell fate promotes neoplastic invasiveness in non-functioning pituitary gonadotroph adenoma via cis-regulatory elements activation.
   Br J Cancer. 2025;133:1454-1470.
   PubMed         Abstract available
   
   

   
   Br J Neurosurg

4. GOACHER E, Al-Munaer M, Aye M, Kounin G, et al
   Delayed regression of atypical meningiomatosis following discontinuation of gender-affirming hormone therapy in a transgender woman: a case report.
   Br J Neurosurg. 2025 Nov 10:1-7. doi: 10.1080/02688697.2025.2586008.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

5. NAYAK R, Rao S, Chowdhury A, A A, et al
   Role of immunohistochemistry in the molecular classification of atypical teratoid/rhabdoid tumor.
   Childs Nerv Syst. 2025;41:349.
   PubMed         Abstract available
   
   
6. EROL A, Ay LA, Bolat E
   Atypical teratoid/rhabdoid tumor of the third ventricle in a pediatric patient: a case report.
   Childs Nerv Syst. 2025;41:345.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

7. PELAK DMJ, Hummer A, Hug PE, Topfer S, et al
   Patient-reported outcomes, neurocognitive functioning and oncologic results of pencil-beam-scanning proton beam therapy for CNS WHO G2 and G3 IDH1-mutant diffuse adult glioma: A single institution experience.
   Int J Radiat Oncol Biol Phys. 2025 Nov 10:S0360-3016(25)06417.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

8. WANG SH, Li HW, Weng JC, Yu YB, et al
   QSM predicts haemorrhage risk in brainstem cavernous malformations: a multicentre prospective study.
   J Neurol Neurosurg Psychiatry. 2025;96:1194-1203.
   PubMed         Abstract available
   
   

   
   J Neurooncol

9. SAMIMI K, Saini AS, Cullison K, Herr J, et al
   EGFR pathway alterations correlate with rapid early progression in glioblastoma.
   J Neurooncol. 2025;176:77.
   PubMed         Abstract available
   
   
10. GUIMARAES MM, Matushita H
    Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy.
    J Neurooncol. 2025;176:75.
    PubMed        
    
    
11. CHOLE V, Moolchandani J, Verma S, Satone S, et al
    PSF-GRBM: brain tumor classification and grading using optimized gated recurrent unit-deep bidirectional long short-term memory.
    J Neurooncol. 2025;176:76.
    PubMed         Abstract available
    
    
12. YANG X, Wang L, Wu H, Li C, et al
    GABA treatment promoting cell apoptosis in meningioma correlates with EGFR/BCL-2/BAX axis.
    J Neurooncol. 2025;176:78.
    PubMed        
    
    
13. BUCCILLI B, Yoon J, Hussein A, Faraji AH, et al
    Correction to: Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study.
    J Neurooncol. 2025;176:79.
    PubMed        
    
    
14. TOTH AJ, Robert SM, Fahy T, Wang SY, et al
    Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosis.
    J Neurooncol. 2025;176:80.
    PubMed         Abstract available
    
    
15. KANN MR, Srinivasan ES, Benedetti JR, Ostrom QT, et al
    Epidemiology and survival of adolescent and young adults with brain metastases compared to older adults.
    J Neurooncol. 2025;176:81.
    PubMed        
    
    
16. DUFFAU H
    Return to intensive sport activities following awake functional-guided surgical resection of IDH-mutated low-grade glioma.
    J Neurooncol. 2025;176:82.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

17. WELCH RL, Fluss RS, Yokoda RT, Himes BT, et al
    Primary sporadic intracranial DICER1 mutant sarcoma with SSTR2 positivity in an adult patient mimicking anaplastic meningioma.
    J Neuropathol Exp Neurol. 2025 Nov 11:nlaf053. doi: 10.1093.
    PubMed        
    
    
18. WENG M, Zhu X
    FOXM1/CENPI axis regulation of proline and arginine metabolism in glioblastoma cells.
    J Neuropathol Exp Neurol. 2025 Nov 4:nlaf121. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

19. HOWARD SD, Liu T, Hsu JY, Zhang D, et al
    Rate of biopsy prior to resection among patients with high-grade glioma: a nationwide database analysis.
    J Neurosurg. 2025 Nov 7:1-9. doi: 10.3171/2025.6.JNS25618.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

20. FYFE I
    Glioblastoma biopsy reveals treatment response.
    Nat Rev Neurol. 2025 Nov 11. doi: 10.1038/s41582-025-01168.
    PubMed        
    
    

    
    Neuro Oncol

21. BRAMAN BC, Raleigh DR
    Mounting evidence implicates medroxyprogesterone acetate in meningioma risk, but mechanisms require further investigation.
    Neuro Oncol. 2025 Nov 12:noaf267. doi: 10.1093.
    PubMed        
    
    
22. TIEK D, Song X, Wu R, Yu X, et al
    Cysteine addiction in drug resistant glioblastoma and therapeutic targeting with designer selenium compounds.
    Neuro Oncol. 2025 Nov 10:noaf265. doi: 10.1093.
    PubMed         Abstract available
    
    
23. GORTER M, Rottgering JG, Belgers V, Blom MEC, et al
    Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma.
    Neuro Oncol. 2025 Nov 9:noaf256. doi: 10.1093.
    PubMed         Abstract available
    
    
24. REN X, Cheng W, Wu A
    Seeing the Whole Picture: AI Aids Integrative Diagnosis of Gliomas from Histopathology.
    Neuro Oncol. 2025 Nov 9:noaf262. doi: 10.1093.
    PubMed        
    
    
25. RYDEN I, Latini F, Munkhammar AA, Hellstrom P, et al
    Reliable cognitive changes the first year following guideline-based treatment of IDH mutated gliomas: a longitudinal multicenter study.
    Neuro Oncol. 2025 Nov 9:noaf263. doi: 10.1093.
    PubMed         Abstract available
    
    
26. ARAKAWA Y, Saito R, Kanemura Y, Mishima K, et al
    Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naive isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas.
    Neuro Oncol. 2025 Nov 8:noaf258. doi: 10.1093.
    PubMed         Abstract available
    
    
27. JOHNSON KC, Tien AC, Jiang J, McNamara J, et al
    Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma.
    Neuro Oncol. 2025 Nov 8:noaf257. doi: 10.1093.
    PubMed         Abstract available
    
    
28. CHAVAZ L, Bagchi A, Dhanda SK, Toutain F, et al
    A Systematic Study of Molecular Diagnosis, Treatment and Prognosis in Infant-Type Hemispheric Glioma): An Individual Patient Data Meta-analysis of 164 patients.
    Neuro Oncol. 2025 Nov 8:noaf264. doi: 10.1093.
    PubMed         Abstract available
    
    
29. YEFET LS, Landry AP, Wang JZ, Liu J, et al
    Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology.
    Neuro Oncol. 2025 Nov 8:noaf252. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

30. AZIZOVA A, Prysiazhniuk Y, Cakmak M, Kaya E, et al
    Visual versus region-of-interest based diffusion evaluation and their diagnostic impact in adult-type diffuse gliomas.
    Neuroradiology. 2025 Nov 8. doi: 10.1007/s00234-025-03832.
    PubMed         Abstract available
    
    

    
    Neurosurgery

31. VAN DER VEKEN J, Poonnoose SI, Bardy C
    Letter: Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant Recurrence.
    Neurosurgery. 2025 Nov 10. doi: 10.1227/neu.0000000000003853.
    PubMed        
    
    
32. YU QS, Yu XG, Yin YH
    Letter: Clinical Prognostic Factors and Molecular Characteristics of Spinal Cord Diffuse Midline Gliomas.
    Neurosurgery. 2025 Nov 10. doi: 10.1227/neu.0000000000003844.
    PubMed        
    
    
33. GECICI NN, Habib A, Zinn PO
    In Reply: Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant Recurrence.
    Neurosurgery. 2025 Nov 10. doi: 10.1227/neu.0000000000003852.
    PubMed        
    
    

    
    Oncogene

34. WESTHOFF MA, Zhou S, Bachem MG, Debatin KM, et al
    Correction: Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells.
    Oncogene. 2025 Nov 12. doi: 10.1038/s41388-025-03628.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.